Bone health in children and adolescents with type 1 and type 2 diabetes (original) (raw)

1. Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 2022;183:109119.
crossref pmid pdf

2. Weber DR, Gordon RJ, Kelley JC, Leonard MB, Willi SM, Hatch-Stein J, et al. Poor glycemic control is associated with impaired bone accrual in the year following a diagnosis of type 1 diabetes. J Clin Endocrinol Metab 2019;104:4511-20.
crossref pmid pmc pdf

3. Mayer-Davis EJ, Lawrence JM, Dabelea D, Divers J, Isom S, Dolan L, et al. Incidence trends of type 1 and type 2 diabetes among youths, 2002-2012. N Engl J Med 2017;376:1419-29.
crossref pmid pmc pdf

4. Chae HW, Seo GH, Song K, Choi HS, Suh J, Kwon A, et al. Incidence and prevalence of type 1 diabetes mellitus among Korean children and adolescents between 2007 and 2017: an epidemiologic study based on a national database. Diabetes Metab J 2020;44:866-74.
crossref pmid pmc pdf

5. Hong YH, Chung IH, Han K, Chung S. Prevalence of type 2 diabetes mellitus among Korean children, adolescents, and adults younger than 30 years: changes from 2002 to 2016. Diabetes Metab J 2022;46:297-306.
crossref pmid pdf

6. Weaver CM, Gordon CM, Janz KF, Kalkwarf HJ, Lappe JM, Lewis R, et al. The National Osteoporosis Foundation's position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations. Osteoporos Int 2016;27:1281-386.
crossref pmid pmc pdf

7. Napoli N, Chandran M, Pierroz DD, Abrahamsen B, Schwartz AV, Ferrari SL. Mechanisms of diabetes mellitus-induced bone fragility. Nat Rev Endocrinol 2017;13:208-19.
crossref pmid pdf

8. Thrailkill KM, Liu L, Wahl EC, Bunn RC, Perrien DS, Cockrell GE, et al. Bone formation is impaired in a model of type 1 diabetes. Diabetes 2005;54:2875-81.
crossref pmid pdf

9. Starup-Linde J, Hygum K, Langdahl BL. Skeletal fragility in type 2 diabetes mellitus. Endocrinol Metab (Seoul) 2018;33:339-51.
crossref pmid pmc pdf

10. Wu B, Fu Z, Wang X, Zhou P, Yang Q, Jiang Y, et al. A narrative review of diabetic bone disease: characteristics, pathogenesis, and treatment. Front Endocrinol (Lausanne) 2022;13:1052592.
crossref pmid pmc pdf

11. Huang Z, Xu Z, Wan R, Hu D, Huang Y. Associations between blood inflammatory markers and bone mineral density and strength in the femoral neck: findings from the MIDUS II study. Sci Rep 2023;13:10662.
crossref pmid pmc pdf

12. Choi YJ, Chung YS. Type 2 diabetes mellitus and bone fragility: special focus on bone imaging. Osteoporos Sarcopenia 2016;2:20-4.
crossref pmid pmc pdf

13. Samelson EJ, Demissie S, Cupples LA, Zhang X, Xu H, Liu CT, et al. Diabetes and deficits in cortical bone density, microarchitecture, and bone size: Framingham HR-pQCT study. J Bone Miner Res 2018;33:54-62.
crossref pmid pdf

14. Shah VN, Shah CS, Snell-Bergeon JK. Type 1 diabetes and risk of fracture: meta-analysis and review of the literature. Diabet Med 2015;32:1134-42.
crossref pmid pmc pdf

15. Onder A, Cetinkaya S, Tunc O, Aycan Z. Evaluation of bone mineral density in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2013;26:1077-81.
crossref pmid pdf

16. Du Caju MV, Rooman RP, op de Beeck L. Longitudinal data on growth and final height in diabetic children. Pediatr Res 1995;38:607-11.
crossref pmid pdf

17. Vanelli M, de Fanti A, Adinolfi B, Ghizzoni L. Clinical data regarding the growth of diabetic children. Horm Res 1992;37 Suppl 3:65-9.
crossref pmid pdf

18. Saha MT, Sievänen H, Salo MK, Tulokas S, Saha HH. Bone mass and structure in adolescents with type 1 diabetes compared to healthy peers. Osteoporos Int 2009;20:1401-6.
crossref pmid pdf

19. Morsczeck C, Moehl C, Götz W, Heredia A, Schäffer TE, Eckstein N, et al. In vitro differentiation of human dental follicle cells with dexamethasone and insulin. Cell Biol Int 2005;29:567-75.
crossref pmid pdf

20. Fulzele K, DiGirolamo DJ, Liu Z, Xu J, Messina JL, Clemens TL. Disruption of the insulin-like growth factor type 1 receptor in osteoblasts enhances insulin signaling and action. J Biol Chem 2007;282:25649-58.
crossref pmid pdf

21. Wang B, Vashishth D. Advanced glycation and glycoxidation end products in bone. Bone 2023;176:116880.
crossref pmid pmc pdf

22. Garnero P. The contribution of collagen crosslinks to bone strength. Bonekey Rep 2012;1:182.
crossref pmid pmc pdf

23. Bathina S, Armamento-Villareal R. The complex pathophysiology of bone fragility in obesity and type 2 diabetes mellitus: therapeutic targets to promote osteogenesis. Front Endocrinol (Lausanne) 2023;14:1168687.
crossref pmid pmc pdf

24. Sharma P, Sharma RK, Gaur K. Understanding the impact of diabetes on bone health: a clinical review. Metabol Open 2024;24:100330.
crossref pmid pmc pdf

25. Cao JJ. Effects of obesity on bone metabolism. J Orthop Surg Res 2011;6:30.
crossref pmid pmc pdf

26. Yang X, Chai M, Lin M. Proportion of vitamin D deficiency in children/adolescents with type 1 diabetes: a systematic review and meta-analysis. BMC Pediatr 2024;24:192.
crossref pmid pmc pdf

27. Thacher TD, Clarke BL. Vitamin D insufficiency. Mayo Clin Proc 2011;86:50-60.
crossref pmid pmc pdf

28. Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis. Osteoporos Int 2007;18:427-44.
crossref pmid pdf

29. Gunczler P, Lanes R, Paoli M, Martinis R, Villaroel O, Weisinger JR. Decreased bone mineral density and bone formation markers shortly after diagnosis of clinical type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2001;14:525-8.
crossref pmid pdf

30. Rizzoli R, Bianchi ML, Garabédian M, McKay HA, Moreno LA. Maximizing bone mineral mass gain during growth for the prevention of fractures in the adolescents and the elderly. Bone 2010;46:294-305.
crossref pmid pdf

31. Hammeed E, Badr HW, Abdallah AA, Hanna WM, Salah N. Osteoporosis in diabetic children. J Am Sci 2010;6:685-90.
crossref pdf

32. Chowdhury S. Puberty and type 1 diabetes. Indian J Endocrinol Metab 2015;19(Suppl 1):S51-4.
crossref pmid pmc pdf

33. Hamada Y, Fujii H, Fukagawa M. Role of oxidative stress in diabetic bone disorder. Bone 2009;45 Suppl 1:S35-8.
crossref pmid pdf

34. Liu H, Xiao H, Lin S, Zhou H, Cheng Y, Xie B, et al. Effect of gut hormones on bone metabolism and their possible mechanisms in the treatment of osteoporosis. Front Pharmacol 2024;15:1372399.
crossref pmid pmc pdf

35. Cronin O, Lanham-New SA, Corfe BM, Gregson CL, Darling AL, Ahmadi KR, et al. Role of the microbiome in regulating bone metabolism and susceptibility to osteoporosis. Calcif Tissue Int 2022;110:273-84.
crossref pmid pdf

36. Zheng Y, Rostami Haji Abadi M, Ghafouri Z, Meira Goes S, Johnston JJD, Nour M, et al. Bone deficits in children and youth with type 1 diabetes: a systematic review and metaanalysis. Bone 2022;163:116509.
crossref pmid pdf

37. Clark EM, Ness AR, Bishop NJ, Tobias JH. Association between bone mass and fractures in children: a prospective cohort study. J Bone Miner Res 2006;21:1489-95.
crossref pmid pmc pdf

38. Chen SC, Shepherd S, McMillan M, McNeilly J, Foster J, Wong SC, et al. Skeletal fragility and its clinical determinants in children with type 1 diabetes. J Clin Endocrinol Metab 2019;104:3585-94.
crossref pmid pdf

39. Madsen JOB, Jørgensen NR, Pociot F, Johannesen J. Bone turnover markers in children and adolescents with type 1 diabetes-A systematic review. Pediatr Diabetes 2019;20:510-22.
crossref pmid pdf

40. Mitchell DM, Caksa S, Joseph T, Bouxsein ML, Misra M. Elevated HbA1c is associated with altered cortical and trabecular microarchitecture in girls with type 1 diabetes. J Clin Endocrinol Metab 2020;105:e1648-56.
crossref pmid pmc pdf

41. Weber DR, Haynes K, Leonard MB, Willi SM, Denburg MR. Type 1 diabetes is associated with an increased risk of fracture across the life span: a population-based cohort study using The Health Improvement Network (THIN). Diabetes Care 2015;38:1913-20.
crossref pmid pmc pdf

42. Kindler JM, Kelly A, Khoury PR, Levitt Katz LE, Urbina EM, Zemel BS. Bone mass and density in youth with type 2 diabetes, obesity, and healthy weight. Diabetes Care 2020;43:2544-52.
crossref pmid pmc pdf

43. Faienza MF, Pontrelli P, Brunetti G. Type 2 diabetes and bone fragility in children and adults. World J Diabetes 2022;13:900-11.
crossref pmid pmc pdf

44. Patsch JM, Burghardt AJ, Yap SP, Baum T, Schwartz AV, Joseph GB, et al. Increased cortical porosity in type 2 diabetic postmenopausal women with fragility fractures. J Bone Miner Res 2013;28:313-24.
crossref pmid pmc pdf

45. Wang Q, Zhang B, Xu Y, Xu H, Zhang N. The relationship between serum osteocalcin concentration and glucose metabolism in patients with type 2 diabetes mellitus. Int J Endocrinol 2013;2013:842598.
crossref pmid pmc pdf

46. Janghorbani M, Van Dam RM, Willett WC, Hu FB. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 2007;166:495-505.
crossref pmid pdf

47. Gordon CM, Leonard MB, Zemel BS. 2013 Pediatric Position Development Conference: executive summary and reflections. J Clin Densitom 2014;17:219-24.
crossref pmid pdf

48. Choong WS, Gallacher S, Ahmed SF. Assessing osteoporosis in the young adult. Eur Endocrinol 2015;11:43-4.
crossref pmid pmc pdf

49. Giangregorio LM, Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, et al. FRAX underestimates fracture risk in patients with diabetes. J Bone Miner Res 2012;27:301-8.
crossref pmid pdf

50. Schwartz AV, Vittinghoff E, Bauer DC, Hillier TA, Strotmeyer ES, Ensrud KE, et al. Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA 2011;305:2184-92.
crossref pmid pmc pdf

51. Leslie WD, Aubry-Rozier B, Lamy O, Hans D. TBS (trabecular bone score) and diabetes-related fracture risk. J Clin Endocrinol Metab 2013;98:602-9.
crossref pmid pdf

52. Sewing L, Potasso L, Baumann S, Schenk D, Gazozcu F, Lippuner K, et al. Bone microarchitecture and strength in long-standing type 1 diabetes. J Bone Miner Res 2022;37:837-47.
crossref pmid pmc pdf

53. Hygum K, Starup-Linde J, Harsløf T, Vestergaard P, Langdahl BL. Mechanisms in endocrinology: diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis. Eur J Endocrinol 2017;176:R137-57.
crossref pmid pdf

54. Armas LA, Akhter MP, Drincic A, Recker RR. Trabecular bone histomorphometry in humans with type 1 diabetes mellitus. Bone 2012;50:91-6.
crossref pmid pdf

55. Sakka SD. Osteoporosis in children and young adults. Best Pract Res Clin Rheumatol 2022;36:101776.
crossref pmid pdf

56. Ciancia S, Högler W, Sakkers RJB, Appelman-Dijkstra NM, Boot AM, Sas TC, et al. Osteoporosis in children and adolescents: how to treat and monitor? Eur J Pediatr 2023;182:501-11.
crossref pmid pdf

57. Munns CF, Shaw N, Kiely M, Specker BL, Thacher TD, Ozono K, et al. Global consensus recommendations on prevention and management of nutritional rickets. J Clin Endocrinol Metab 2016;101:394-415.
crossref pmid pmc pdf

58. Tan VP, Macdonald HM, Kim S, Nettlefold L, Gabel L, Ashe MC, et al. Influence of physical activity on bone strength in children and adolescents: a systematic review and narrative synthesis. J Bone Miner Res 2014;29:2161-81.
crossref pmid pdf

59. Ward LM, Weber DR, Munns CF, Högler W, Zemel BS. A contemporary view of the definition and diagnosis of osteoporosis in children and adolescents. J Clin Endocrinol Metab 2020;105:e2088-97.
crossref pmid pmc pdf